A European multinational cost-effectiveness analysis of empagliflozin in heart failure with reduced ejection fraction
Ali Tafazzoli, Odette S. Reifsnider, Leana Bellanca, Jack Ishak, Marc Carrasco, Pal Rakonczai, Matthew Stargardter, Stephan Linden
| Year of publication: |
2023
|
|---|---|
| Authors: | Tafazzoli, Ali ; Reifsnider, Odette S. ; Bellanca, Leana ; Ishak, Jack ; Carrasco, Marc ; Rakonczai, Pal ; Stargardter, Matthew ; Linden, Stephan |
| Published in: |
The European journal of health economics. - Berlin : Springer, ISSN 1618-7601, ZDB-ID 2011428-X. - Vol. 24.2023, 9, p. 1441-1454
|
| Subject: | Cost-effectiveness | Empagliflozin | Heart failure | Hospitalisation | Reduced ejection fraction | Sodium–glucose cotransporter-2 inhibitor | Kosten-Wirksamkeits-Analyse | Cost-effectiveness analysis | Multinationales Unternehmen | Transnational corporation | Herzkrankheit | Heart disease | EU-Staaten | EU countries |
freely available
| Type of publication: | Article |
|---|---|
| Type of publication (narrower categories): | Aufsatz in Zeitschrift ; Article in journal |
| Language: | English |
| Other identifiers: | 10.1007/s10198-022-01555-6 [DOI] |
| Source: | ECONIS - Online Catalogue of the ZBW |
Persistent link: https://www.econbiz.de/10014427300